SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-049924
Filing Date
2021-09-27
Accepted
2021-09-27 09:14:13
Documents
7
Period of Report
2021-09-27

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea147939-6k_cellectbiotech.htm 6-K 24191
2 CELLECT BIOTECHNOLOGY REPORTS RESULTS OF SHAREHOLDERS' MEETING, AMENDMENT OF MER ea147939ex99-1_cellect.htm EX-99.1 18651
3 AMENDMENT MADE AS OF SEPTEMBER 24, 2021, TO THE AGREEMENT AND PLAN OF MERGER AND ea147939ex99-2_cellect.htm EX-99.2 6769
4 AMENDMENT MADE AS OF SEPTEMBER 26, 2021, TO THE AMENDED AND RESTATED SHARE TRANS ea147939ex99-3_cellect.htm EX-99.3 8776
5 GRAPHIC ex99-1_001.jpg GRAPHIC 2204
6 GRAPHIC ex99-2_001.jpg GRAPHIC 2904
7 GRAPHIC ex99-3_001.jpg GRAPHIC 2904
  Complete submission text file 0001213900-21-049924.txt   70892
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Cellect Biotechnology Ltd. (Filer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-37846 | Film No.: 211279245
SIC: 3841 Surgical & Medical Instruments & Apparatus